BSD Medical Corporation Announces Investor & Analyst Conference Call

  BSD Medical Corporation Announces Investor & Analyst Conference Call  Live Conference Call and Webcast Scheduled for Thursday, July 10 at 2:00 p.m.              Eastern Time/12:00 p.m. Mountain Time; RSVP Required  Business Wire  SALT LAKE CITY -- June 30, 2014  BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that it will host an Investor & Analyst Update Call and live webcast on Thursday, July 10, 20114 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time. The call will be hosted by Harold Wolcott, President and William Barth, CFO.  Individuals interested in participating in the conference call may do so by visiting the Investor Relations section of the Company's website at or by dialing 800.860.2442 from the United States, or 412.858.4600 from outside the United States, and referencing “BSD Medical.” We request that you RSVP to the conference call by emailing before 4:00 p.m. Eastern time on Tuesday, July 8, 2014.  A telephone replay will be available through July 18, 2014, by dialing 877.344.7529 from the United States, or 412.317.0088 from outside the United States, and entering conference ID 10048867. A webcast replay will be available for 90 days.  About BSD Medical Corporation  BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy, which is delivered using focused radiofrequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s MicroThermX^® microwave ablation system has been developed as a stand-alone therapy to employ precision-guided microwave energy to ablate (destroy) soft tissue. The Company has developed extensive intellectual property, multiple products in the market and established distribution in the United States, Europe and Asia. Certain of the Company’s products have received regulatory approvals and clearances in the United States, Europe and China.  For further information visit BSD Medical's website at  Forward-Looking Statements  Statements contained in this press release that are not historical facts, including statements relating to our 2014 plans, are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission, including the market demand for our MicroThermXproducts and the regulatory requirements we face. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date, except as required by law.  Contact:  Financial Profiles Tricia Ross, 310-622-8226  
Press spacebar to pause and continue. Press esc to stop.